BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15953677)

  • 1. Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy.
    Marty C; Langer-Machova Z; Sigrist S; Schott H; Schwendener RA; Ballmer-Hofer K
    Cancer Lett; 2006 Apr; 235(2):298-308. PubMed ID: 15953677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
    Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
    BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
    Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.
    Zhao A; Nunez-Cruz S; Li C; Coukos G; Siegel DL; Scholler N
    J Immunol Methods; 2011 Jan; 363(2):221-32. PubMed ID: 20837020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.
    Yuan X; Yang M; Chen X; Zhang X; Sukhadia S; Musolino N; Bao H; Chen T; Xu C; Wang Q; Santoro S; Ricklin D; Hu J; Lin R; Yang W; Li Z; Qin W; Zhao A
    Cancer Immunol Immunother; 2017 Mar; 66(3):367-378. PubMed ID: 27933426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting human cancer cells with VEGF receptor-2-directed liposomes.
    Rubio Demirovic A; Marty C; Console S; Zeisberger SM; Ruch C; Jaussi R; Schwendener RA; Ballmer-Hofer K
    Oncol Rep; 2005 Feb; 13(2):319-24. PubMed ID: 15643518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of recombinant protein ScFv(CD11c)-TRP2 for tumor therapy from inclusion bodies in Escherichia coli.
    Kou G; Shi S; Wang H; Tan M; Xue J; Zhang D; Hou S; Qian W; Wang S; Dai J; Li B; Guo Y
    Protein Expr Purif; 2007 Mar; 52(1):131-8. PubMed ID: 17027283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid isolation of intrabody candidates by using an optimized non-immune phage antibody library.
    Nagano K; Imai S; Mukai Y; Nakagawa S; Abe Y; Kamada H; Tsunoda S; Tsutsumi Y
    Pharmazie; 2009 Apr; 64(4):238-41. PubMed ID: 19435141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening human antibody libraries against carcinoma cells by affinity purification and polymerase chain reaction.
    Reiersen H; Berntsen G; Stassar M; Cochlovius B
    J Immunol Methods; 2008 Jan; 330(1-2):44-56. PubMed ID: 18082761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
    Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
    J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterization of an active single-chain variable fragment antibody recognizing CD25.
    Muramatsu H; Yoshikawa K; Hayashi T; Takasu S; Kawada Y; Uchida K; Sato S; Takahashi T; Saga S; Ueda R
    Cancer Lett; 2005 Jul; 225(2):225-36. PubMed ID: 15978327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective induction of cell death on adult T-cell leukaemia cells by HLA-DRbeta-specific small antibody fragment isolated from human antibody phage library.
    Muraoka S; Ito Y; Kamimura M; Baba M; Arima N; Suda Y; Hashiguchi S; Torikai M; Nakashima T; Sugimura K
    J Biochem; 2009 Jun; 145(6):799-810. PubMed ID: 19270058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 2. Expression, purification, and characterization of recombinant single chain antibodies.
    Zhang W; Matsumoto-Takasaki A; Kusada Y; Sakaue H; Sakai K; Nakata M; Fujita-Yamaguchi Y
    Biochemistry; 2007 Jan; 46(1):263-70. PubMed ID: 17198397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
    Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
    Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
    Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage-derived monoclonal anti-Lu.
    Richard M; Perreault J; Gane P; el Nemer W; Cartron JP; St-Louis M
    Transfusion; 2006 Jun; 46(6):1011-7. PubMed ID: 16734819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution.
    Krishnaswamy S; Kabir ME; Miyamoto M; Furuichi Y; Komiyama T
    Anal Biochem; 2009 Dec; 395(1):16-24. PubMed ID: 19665444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of a recombinant single chain Fv antibody to von Willebrand factor A1 domain from phage display library.
    Zhu H; Wang Y; Jiang M; Ji S; Bai X; Ruan C
    Thromb Res; 2005; 116(5):385-91. PubMed ID: 16122551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation by phage display of recombinant antibodies able to block adherence of Escherichia coli mediated by the K99 colonisation factor.
    Golchin M; Aitken R
    Vet Immunol Immunopathol; 2008 Feb; 121(3-4):321-31. PubMed ID: 18036670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.